Lincoln Pharmaceuticals Ltd
NSE: LINCOLN BSE: 531633
₹654.30
(6.25%)
Sat, 14 Feb 2026, 08:33 am
Market Cap12.29B
PE Ratio16.38
Dividend0.29
Health Technology
Pharmaceuticals: Major
24.5KLincoln Pharmaceuticals Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 552.34M | 633.94M | 862.32M | 1.14B | 1.27B | 1.83B | 1.72B | 1.90B | 2.07B | 2.61B | 4.00B | 3.50B | 3.55B | 3.57B | 3.77B | 4.15B | 4.69B | 5.06B | 5.72B | 6.16B |
| Gross profit | 147.87M | 184.90M | 228.60M | 310.17M | 368.55M | 388.18M | 363.43M | 370.75M | 380.02M | 477.36M | 757.10M | 738.19M | 893.78M | 953.19M | 1.03B | 1.20B | 1.45B | 1.31B | 1.42B | 1.56B |
| Operating expenses (excl. COGS) | -111.25M | -128.05M | -141.69M | -223.95M | -259.94M | -305.30M | -276.30M | -272.58M | -239.17M | -306.14M | -387.36M | -415.79M | -476.38M | -423.89M | -520.89M | -478.75M | -590.97M | -531.12M | -587.82M | -725.83M |
| Selling/general/admin expenses, total | -108.75M | -123.73M | -141.69M | -219.95M | -259.94M | -305.30M | -276.30M | -272.58M | -239.17M | -306.14M | -345.77M | -386.38M | -454.92M | -402.32M | -505.90M | -435.94M | -557.97M | -502.10M | -562.40M | -695.51M |
| Research & development | 0 | — | — | — | — | — | — | -635.82K | -250.00K | — | -55.88M | -52.98M | -70.92M | -89.38M | -83.00M | -93.63M | — | -117.69M | -109.71M | -106.00M |
| Selling/general/admin expenses, other | -108.75M | -123.73M | -141.69M | -219.95M | -259.94M | -305.30M | -276.30M | -271.95M | -238.92M | -306.14M | -289.89M | -333.41M | -384.00M | -312.94M | -422.91M | -435.94M | -557.97M | -384.41M | -452.69M | -589.51M |
| Other operating expenses, total | -2.50M | -4.32M | 0 | -4.00M | 0 | 0 | 0 | 0 | 0 | 0 | -41.58M | -29.40M | -21.46M | -21.57M | -14.99M | -42.81M | -33.00M | -29.02M | -25.42M | -30.32M |
| Operating income | 36.62M | 56.85M | 86.91M | 86.22M | 108.61M | 82.89M | 87.13M | 98.17M | 140.85M | 171.22M | 369.74M | 322.40M | 417.40M | 529.30M | 507.78M | 720.15M | 860.33M | 779.91M | 832.22M | 838.76M |
| Non-operating income, total | -6.04M | -12.83M | -21.70M | -23.59M | -22.77M | -533.22K | -13.25M | 15.67M | -20.14M | 27.24M | -39.08M | 50.94M | 45.07M | 92.64M | 164.54M | 117.06M | 99.06M | 224.88M | 390.21M | 253.13M |
| Interest expense, net of interest capitalized | -8.30M | -12.57M | -21.67M | -14.21M | -15.99M | -43.14M | -75.91M | -71.92M | -69.70M | -83.77M | -99.62M | -66.61M | -54.11M | -39.97M | -20.18M | -15.62M | -14.51M | -20.30M | -14.65M | -18.83M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 2.26M | -256.34K | -35.23K | -9.38M | -6.79M | 42.61M | 62.66M | 90.93M | 53.24M | 114.14M | 65.38M | 118.97M | 90.69M | 122.19M | 172.28M | 103.62M | 86.30M | 202.65M | 194.33M | 223.04M |
| Non-operating interest income | 0 | 0 | 0 | 0 | 0 | 17.64M | 3.15M | 7.25M | 10.55M | 34.98M | 36.59M | 23.13M | 11.82M | 11.91M | 15.00M | 22.37M | 50.28M | 61.71M | 70.23M | 72.20M |
| Miscellaneous non-operating expense | 2.26M | -256.34K | -35.23K | -9.38M | -6.79M | 24.97M | 59.51M | 83.68M | 42.68M | 79.16M | 28.79M | 95.84M | 78.88M | 110.27M | 157.28M | 81.25M | 36.01M | 140.94M | 124.10M | 150.84M |
| Unusual income/expense | — | 0 | 0 | — | — | — | — | -3.34M | -3.68M | -3.13M | -4.84M | -1.42M | 8.49M | 10.43M | 12.44M | 29.05M | 27.28M | 42.53M | 210.53M | 48.92M |
| Pretax income | 30.58M | 44.02M | 65.20M | 62.63M | 85.84M | 82.35M | 73.88M | 113.84M | 120.71M | 198.46M | 330.65M | 373.34M | 462.47M | 621.94M | 672.32M | 837.21M | 959.39M | 1.00B | 1.22B | 1.09B |
| Taxes | -4.64M | -13.55M | -18.58M | -20.00M | -24.79M | -23.86M | -22.60M | -18.50M | -18.87M | -48.04M | -92.66M | -92.01M | -115.98M | -134.56M | -157.66M | -214.71M | -265.84M | -275.81M | -289.38M | -268.42M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | -92.90K | 1.28M | 4.70M | -292.85K | -1.17M | -103.44K | -264.51K | -288.00K | -271.00K | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.00K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 25.94M | 30.48M | 46.63M | 42.63M | 61.04M | 58.50M | 51.19M | 96.62M | 106.54M | 150.12M | 236.82M | 281.23M | 346.23M | 487.10M | 514.39M | 622.50M | 693.55M | 728.99M | 933.05M | 823.46M |
| Net income | 25.94M | 30.48M | 46.63M | 42.63M | 61.04M | 58.50M | 51.19M | 96.62M | 106.54M | 150.12M | 236.82M | 281.23M | 346.23M | 487.10M | 514.39M | 622.50M | 693.55M | 728.99M | 933.05M | 823.46M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 25.94M | 30.48M | 46.63M | 42.63M | 61.04M | 58.50M | 51.19M | 96.62M | 106.54M | 150.12M | 236.82M | 281.23M | 346.23M | 487.10M | 514.39M | 622.50M | 693.55M | 728.99M | 933.05M | 823.46M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 41.81M | 62.43M | 93.97M | 94.85M | 120.24M | 99.58M | 106.46M | 124.65M | 176.12M | 216.90M | 418.40M | 377.55M | 478.52M | 596.31M | 581.04M | 795.75M | 941.21M | 871.58M | 938.46M | 967.75M |
| EBIT | 36.62M | 56.85M | 86.91M | 86.22M | 108.61M | 82.89M | 87.13M | 98.17M | 140.85M | 171.22M | 369.74M | 322.40M | 417.40M | 529.30M | 507.78M | 720.15M | 860.33M | 779.91M | 832.22M | 838.76M |
| Total operating expenses | -515.72M | -577.09M | -775.41M | -1.05B | -1.16B | -1.74B | -1.63B | -1.80B | -1.93B | -2.44B | -3.63B | -3.18B | -3.13B | -3.05B | -3.27B | -3.43B | -3.83B | -4.28B | -4.89B | -5.32B |
| Prepaid expenses | 17.80M | — | — | 68.12M | 54.18M | 50.27M | — | — | — | — | 488.65K | 5.76M | 12.71M | 10.13M | 10.89M | 11.37M | 9.28M | 19.36M | 16.25M | 18.09M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | 3.91M | — | 0 | 15.27M | 35.40M | 1.18M | 8.21M | 13.24M | 33.85M |
| Capital and operating lease obligations | 23.48M | 0 | 0 | 5.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 14.97M | 14.92M | 15.66M | 22.25M | 28.59M | 43.06M | 52.54M | 47.49M | 39.75M | 47.91M | 70.39M | 103.53M | 99.12M | 65.14M | 64.26M | 64.56M | 69.26M | 86.46M | 123.89M | 141.89M |
| Deferred income, non-current | 0 | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 43.03M | 41.75M | 37.05M | 29.26M | 1.94M | 3.00M | 3.27M | 3.55M | 3.82M | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | — | — | — | — | — | 8.91M | -19.18M | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -9.13M | -9.13M | 0 | -9.13M | -13.57M | -15.88M | -11.37M | -11.45M | -11.45M | -11.45M | -19.72M | -19.57M | -28.75M | -36.17M | -72.33M | 0 | -30.00M | -30.05M | -30.05M | -36.05M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800